Zavesca TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: miglustat
Pack: Zavesca 100 mg capsule, 90, blister pack
Brand name
(ARTG)
: ZAVESCA miglustat 100 mg capsules blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Zavesca is indicated for the oral treatment of patients with mild to moderate Type 1 Gaucher disease, for whom enzyme replacement therapy is not a therapeutic option. ZAVESCA is indicated for the treatment of the progressive neurological manifestations in adult and paediatric patients with Niemann-Pick type C disease.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Oral
- White capsule with "OGT918" printed in black on the cap and "100" printed on the body.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Shelf lifetime is 5 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 90 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient miglustat
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
